Literature DB >> 20610233

Depressive symptoms affect the relationship of N-terminal pro B-type natriuretic peptide to cardiac event-free survival in patients with heart failure.

Eun Kyeung Song1, Debra K Moser, Susan K Frazier, Seongkum Heo, Misook L Chung, Terry A Lennie.   

Abstract

BACKGROUND: Both N-terminal pro B-type natriuretic peptide (NT-pro BNP) and depressive symptoms independently predict cardiac events in heart failure (HF) patients. However, the relationship among NT-pro BNP, depressive symptoms, and cardiac event is unknown. METHODS AND
RESULTS: Blood was drawn to measure NT-pro BNP and depressive symptoms were measured by the Patient Health Questionnaire 9 (PHQ-9) among 210 patients with HF. Data about cardiac event-free survival were collected for the average follow-up period of 397 days. Cox proportional hazards regression with survival curves were used to determine the relationship of NT-pro BNP and depressive symptoms to cardiac event-free survival. Higher NT-pro-BNP confers greater risk of cardiac events among those with depressive symptoms than those without depressive symptoms (P for the interaction = .029). Patients with NT-pro BNP > 581 pg/mL and total PHQ-9 score >/= 10 had a 5.5 times higher risk for cardiac events compared with patients with NT-pro BNP </= 581 pg/mL and total PHQ-9 score < 10 (P = .001).
CONCLUSIONS: The prognostic association of NT-pro BNP with cardiac event-free survival in patients with HF differed by the presence of depressive symptoms. Monitoring and treatment of depressive symptoms may be important for improving cardiac event-free survival in patients with HF. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20610233      PMCID: PMC2901242          DOI: 10.1016/j.cardfail.2010.01.006

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  36 in total

Review 1.  Epidemiology of heart failure.

Authors:  L W Miller; E D Missov
Journal:  Cardiol Clin       Date:  2001-11       Impact factor: 2.213

2.  Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group.

Authors:  A M Richards; R Doughty; M G Nicholls; S MacMahon; N Sharpe; J Murphy; E A Espiner; C Frampton; T G Yandle
Journal:  J Am Coll Cardiol       Date:  2001-06-01       Impact factor: 24.094

3.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

4.  More 'malignant' than cancer? Five-year survival following a first admission for heart failure.

Authors:  S Stewart; K MacIntyre; D J Hole; S Capewell; J J McMurray
Journal:  Eur J Heart Fail       Date:  2001-06       Impact factor: 15.534

Review 5.  The burden of chronic congestive heart failure in older persons: magnitude and implications for policy and research.

Authors:  Frederick A Masoudi; Edward P Havranek; Harlan M Krumholz
Journal:  Heart Fail Rev       Date:  2002-01       Impact factor: 4.214

6.  A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study.

Authors:  R Kazanegra; V Cheng; A Garcia; P Krishnaswamy; N Gardetto; P Clopton; A Maisel
Journal:  J Card Fail       Date:  2001-03       Impact factor: 5.712

7.  Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction.

Authors:  B Stanek; B Frey; M Hülsmann; R Berger; B Sturm; J Strametz-Juranek; J Bergler-Klein; P Moser; A Bojic; E Hartter; R Pacher
Journal:  J Am Coll Cardiol       Date:  2001-08       Impact factor: 24.094

8.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

9.  Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath.

Authors:  John G Lainchbury; Elizabeth Campbell; Christopher M Frampton; Timothy G Yandle; M Gary Nicholls; A Mark Richards
Journal:  J Am Coll Cardiol       Date:  2003-08-20       Impact factor: 24.094

10.  N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure.

Authors:  C Fisher; C Berry; L Blue; J J Morton; J McMurray
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

View more
  13 in total

1.  Health Literacy Predicts Morbidity and Mortality in Rural Patients With Heart Failure.

Authors:  Debra K Moser; Susan Robinson; Martha J Biddle; Michele M Pelter; Thomas S Nesbitt; Jeffery Southard; Lawton Cooper; Kathleen Dracup
Journal:  J Card Fail       Date:  2015-04-20       Impact factor: 5.712

2.  Stress, cognitive appraisal, coping, and event free survival in patients with heart failure.

Authors:  Abdullah S Alhurani; Rebecca Dekker; Muayyad Ahmad; Jennifer Miller; Khalil M Yousef; Basel Abdulqader; Ibrahim Salami; Terry A Lennie; David C Randall; Debra K Moser
Journal:  Heart Lung       Date:  2018-04-04       Impact factor: 2.210

3.  The Association Between Depressive Symptoms and N-Terminal Pro-B-Type Natriuretic Peptide With Functional Status in Patients With Heart Failure.

Authors:  Zyad T Saleh; Jia-Rong Wu; Ibrahim Salami; Khalil Yousef; Terry A Lennie
Journal:  J Cardiovasc Nurs       Date:  2018 Jul/Aug       Impact factor: 2.083

4.  'It could be worse ... lot's worse!' Why health-related quality of life is better in older compared with younger individuals with heart failure.

Authors:  Debra K Moser; Seongkum Heo; Kyoung Suk Lee; Muna Hammash; Barbara Riegel; Terry A Lennie; Cynthia Arslanian-Engoren; Gia Mudd-Martin; Nancy Albert; John Watkins
Journal:  Age Ageing       Date:  2013-07-05       Impact factor: 10.668

Review 5.  BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure.

Authors:  Mark Oremus; Andrew Don-Wauchope; Robert McKelvie; Pasqualina L Santaguida; Stephen Hill; Cynthia Balion; Ronald Booth; Judy A Brown; Usman Ali; Amy Bustamam; Nazmul Sohel; Parminder Raina
Journal:  Heart Fail Rev       Date:  2014-08       Impact factor: 4.214

6.  The association of co-morbid symptoms of depression and anxiety with all-cause mortality and cardiac rehospitalization in patients with heart failure.

Authors:  Abdullah S Alhurani; Rebecca L Dekker; Mona A Abed; Amani Khalil; Marwa H Al Zaghal; Kyoung Suk Lee; Gia Mudd-Martin; Martha J Biddle; Terry A Lennie; Debra K Moser
Journal:  Psychosomatics       Date:  2014-06-02       Impact factor: 2.386

7.  Association of somatic and cognitive depressive symptoms and biomarkers in acute myocardial infarction: insights from the translational research investigating underlying disparities in acute myocardial infarction patients' health status registry.

Authors:  Kim G Smolderen; John A Spertus; Kimberly J Reid; Donna M Buchanan; Viola Vaccarino; Judith H Lichtman; David B Bekelman; Paul S Chan
Journal:  Biol Psychiatry       Date:  2011-09-08       Impact factor: 13.382

8.  Perceived social support predicted quality of life in patients with heart failure, but the effect is mediated by depressive symptoms.

Authors:  Misook L Chung; Debra K Moser; Terry A Lennie; Susan K Frazier
Journal:  Qual Life Res       Date:  2012-10-18       Impact factor: 4.147

9.  Psychometric properties of the Symptom Status Questionnaire-Heart Failure.

Authors:  Seongkum Heo; Debra K Moser; Susan J Pressler; Sandra B Dunbar; Gia Mudd-Martin; Terry A Lennie
Journal:  J Cardiovasc Nurs       Date:  2015 Mar-Apr       Impact factor: 2.083

10.  Antidepressants do not improve event-free survival in patients with heart failure when depressive symptoms remain.

Authors:  Misook L Chung; Rebecca L Dekker; Terry A Lennie; Debra K Moser
Journal:  Heart Lung       Date:  2013-01-07       Impact factor: 2.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.